Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Fig. 1

Study schema. a A prospective observational study in which plasma samples were collected from patients with acquired resistance to afatinib (N=51). b A comparison study of detection of EGFR driver and T790M mutation in plasm as assessed using the cobas test in between patients treated with afatinib as first-line setting enrolled in a prospective observation study and patients treated with G/E as first-line setting in a retrospective study (N=62)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us